ANTI-INFLAMMATORY AND ANTI-FIBROTIC EFFECTS OF A SELECTIVE PARP-1 INHIBITOR IN A MURINE MODEL OF BLEOMYCIN-INDUCED LUNG FIBROSIS

被引：0
|
作者：
Durante, M. [1 ]
Lanzi, C. [1 ]
Pini, A. [1 ]
Boccalini, G. [1 ]
Moroni, F. [1 ]
Masini, E. [1 ]
Lucarini, L. [1 ]
机构：
[1] Univ Florence, Pharmacol Sect, Dept NEUROFARBA, I-50139 Florence, Italy
来源：
INFLAMMATION RESEARCH | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [1] Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats
    Tulek, Baykal
    Kiyan, Esen
    Toy, Hatice
    Kiyici, Aysel
    Narin, Cuneyt
    Suerdem, Mecit
    CLINICAL AND INVESTIGATIVE MEDICINE, 2011, 34 (06): : E341 - E348
  • [2] Anti-inflammatory and anti-fibrotic effects of JNJ7777120 and naproxen in an in vivo model of bleomycin-induced lung fibrosis
    Rosa, A. C.
    Pini, A.
    Lucarini, L.
    Thurmont, R. T.
    Bani, D.
    Masini, E.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S5 - S5
  • [3] Anti-Fibrotic Effect of Ajulemic Acid in Bleomycin-Induced Lung Fibrosis
    Lucattelli, Monica
    Fineschi, Silvia
    Selvi, Enrico
    Gonzales, Estrella Garcia
    Balistrieri, Epifania
    Lorenzini, Sauro
    Galeazzi, Mauro
    Distler, Jorg
    Lungarella, Giuseppe
    FASEB JOURNAL, 2015, 29
  • [4] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin-induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [5] Effects of a Leukotriene B4 Receptor Antagonist, an Anti-Inflammatory and Anti-Fibrotic Agent, on Bleomycin-Induced Pulmonary Fibrosis
    Izumo, T.
    Kondo, M.
    Nagara, N.
    Iritani, E.
    Tamaoki, J.
    Nagai, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow–Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats
    E. S. Gad
    A. A. A. Salama
    M. F. El-Shafie
    H. M. M. Arafa
    R. M. Abdelsalam
    M. Khattab
    Inflammation, 2020, 43 : 123 - 134
  • [7] The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats
    Gad, E. S.
    Salama, A. A. A.
    El-Shafie, M. F.
    Arafa, H. M. M.
    Abdelsalam, R. M.
    Khattab, M.
    INFLAMMATION, 2020, 43 (01) : 123 - 134
  • [8] ANTI-INFLAMMATORY AND ANTI-FIBROTIC EFFECTS OF INTRAVENOUS ADIPOSE-DERIVED STEM CELL TRANSPLANTATION IN A MOUSE MODEL OF BLEOMYCIN-INDUCED SCLERODERMA
    Suzuka, Takayasu
    Kotani, Takuya
    Matsuda, Shogo
    Masaaki, I. I.
    Takeuchi, Tohru
    Arawaka, Shigeki
    Nagai, Koji
    Wada, Yumiko
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 456 - 457
  • [9] Analysis of the Anti-fibrotic Potential of JAK Inhibitors in a Bleomycin-induced Pulmonary Fibrosis Model
    Murakami, K.
    Nishimura, H.
    Kawano, H.
    Danzan, N.
    Yamashita, Y.
    Haji, K.
    Naito, N.
    Koyama, K.
    Sato, S.
    Nishioka, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] ANTI-FIBROTIC EFFECTS OF CYCLOPHOSPHAMIDE ON BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA
    Ozgen, M.
    Koca, S.
    Ustundag, B.
    Ozercan, I.
    Dagli, F.
    Isik, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S159 - S159
12345